Cargando…

Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study

BACKGROUND: Evaluating the effect on primary lesions is important in determining treatment strategies for esophageal cancer. The Response Evaluation Criteria in Solid Tumors system, which employs the longest diameter for measuring tumors, is commonly used for evaluating treatment effects. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taniyama, Yusuke, Murakami, Kentaro, Yoshida, Naoya, Takahashi, Kozue, Matsubara, Hisahiro, Baba, Hideo, Kamei, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428108/ https://www.ncbi.nlm.nih.gov/pubmed/34496769 http://dx.doi.org/10.1186/s12885-021-08747-y

Ejemplares similares

The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study)
por: Tanaka, Yoshihiro, et al.
Publicado: (2018)

Why is endosonography insufficient for residual diagnosis after neoadjuvant therapy for esophageal cancer? Solutions using muscle layer evaluation
por: Yonemoto, Shohei, et al.
Publicado: (2022)

RECIST rules
por: Sohaib, Aslam
Publicado: (2012)

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
por: Kono, Koji, et al.
Publicado: (2012)

Chronology of gastrointestinal cancer
por: Murakami, Kentaro, et al.
Publicado: (2017)

Definitive Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil for Advanced Cervical Esophageal Cancer: A Medium-Term Outcome
por: Okamoto, Hiroshi, et al.
Publicado: (2022)

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
por: van Persijn van Meerten, Els L., et al.
Publicado: (2009)

Advances in the surgical treatment of esophageal cancer since 1965
por: Matsubara, Hisahiro
Publicado: (2020)

Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
por: Baba, Yoshifumi, et al.
Publicado: (2017)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

iRECIST: how to do it
por: Persigehl, Thorsten, et al.
Publicado: (2020)

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
por: Manitz, Juliane, et al.
Publicado: (2022)

Tumor size measurements of pancreatic cancer with neoadjuvant therapy based on RECIST guidelines: is MRI as effective as CT?
por: Yang, Panpan, et al.
Publicado: (2023)

Preserving the Mucosa to the Maximum Possible Extent for Endoscopic Submucosal Dissection of Subcircumferential Superficial Esophageal Carcinoma
por: Uesato, Masaya, et al.
Publicado: (2018)

Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma
por: Akaishi, Ryujiro, et al.
Publicado: (2022)

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
por: Sato, Yozo, et al.
Publicado: (2013)

Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
por: Zhou, Meng, et al.
Publicado: (2021)

Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report
por: Kaneko, Hiromi, et al.
Publicado: (2022)

Comparison of RECIST 1.0 and RECIST 1.1 in Patients with Metastatic Cancer: A Pooled Analysis
por: Kim, Jung Han, et al.
Publicado: (2015)

HO‐1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy
por: Akaishi, Ryujiro, et al.
Publicado: (2021)

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
por: Kano, Masayuki, et al.
Publicado: (2019)

Acute esophageal necrosis with esophagus perforation treated by thoracoscopic subtotal esophagectomy and reconstructive surgery on a secondary esophageal stricture: a case report
por: Akaishi, Ryujiro, et al.
Publicado: (2019)

RECIST Applied to Realistic Tumor Models
por: Levine, Zachary H., et al.
Publicado: (2011)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

A case of small-cell esophageal cancer with chronic renal failure undergoing hemodialysis safely treated with cisplatin and etoposide
por: Murakami, Kentaro, et al.
Publicado: (2011)

Role of sirtuins in esophageal cancer: Current status and future prospects
por: Otsuka, Ryota, et al.
Publicado: (2022)

Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines
por: Matsumoto, Yasunori, et al.
Publicado: (2020)

Gastric endoscopic submucosal dissection via gastrostoma before the second operation for esophageal perforation: A case report
por: Sasaki, Takuma, et al.
Publicado: (2018)

Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma
por: Sekino, Nobufumi, et al.
Publicado: (2019)

Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy
por: Choi, Hyun Chang, et al.
Publicado: (2015)

Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review
por: Kim, Jung Han
Publicado: (2016)

Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma
por: Matsumoto, Yasunori, et al.
Publicado: (2016)

Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report
por: Hirose, Wataru, et al.
Publicado: (2021)

A potential preventive method for scar stenosis after esophageal endoscopic mucosal resection using human amniotic epithelial cells in a porcine model
por: Konno, Yuji, et al.
Publicado: (2022)

Esophagectomy for Esophageal Cancer in a Patient with Protein C Deficiency: A Case Report
por: Ujiie, Naoto, et al.
Publicado: (2020)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

Comprehensive registry of esophageal cancer in Japan, 2013
por: Watanabe, Masayuki, et al.
Publicado: (2020)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
por: Baba, Yoshifumi, et al.
Publicado: (2021)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

RECIST criteria: our experience in daily practice
por: De Luca, S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h5u521gl3sqgth87ufuululchm